← All themes Genomics & Gene Editing

Gene Therapy

Gene therapy delivers a working copy of a gene, or a correction to a faulty one, usually once and for life. Manufacturing the delivery vector is often harder than designing the therapy.

131 stocks

#	Name	Funds holding	Growth	Growth %	Fund value
101	101 IN8bio INAB $11.7M	–	–	–	–
102	102 MiNK Therapeutics INKT $50.7M	–	–	–	–
103	103 Century Therapeutics IPSC $272M	–	–	–	–
104	KRBP 104 DELISTED Kiromic BioPharma, Inc. Common Stock KRBP	–	–	–	–
105	105 Kyverna Therapeutics KYTX $369M	–	–	–	–
106	LGVN 106 Longeveron LGVN $4.78M	–	–	–	–
107	107 Lexeo Therapeutics LXEO $227M	–	–	–	–
108	108 Lyell Immunopharma LYEL $201M	–	–	–	–
109	109 Metagenomi Therapeutics MGX $31.9M	–	–	–	–
110	110 NewcelX Ltd NCEL $16.5M	–	–	–	–
111	111 DELISTED NKGen Biotech, Inc. Common Stock NKGN	–	–	–	–
112	112 Nkarta NKTX $138M	–	–	–	–
113	OBX 113 Obsidian Therapeutics OBX $754M	–	–	–	–
114	114 PharmaCyte Biotech PMCB $3.84M	–	–	–	–
115	115 Prime Medicine PRME $655M	–	–	–	–
116	116 ProKidney PROK $305M	–	–	–	–
117	117 DELISTED Poseida Therapeutics, Inc. Common Stock PSTX	–	–	–	–
118	118 Sana Biotechnology SANA $742M	–	–	–	–
119	SCPS 119 DELISTED Scopus BioPharma Inc. Common Stock SCPS	–	–	–	–
120	SCTX 120 Scribe Therapeutics Inc SCTX $392M	–	–	–	–
121	SGTX 121 DELISTED Sigilon Therapeutics, Inc. Common Stock SGTX	–	–	–	–
122	SLBT 122 SL Science Holding Ltd SLBT $869M	–	–	–	–
123	123 Senti Biosciences Holdings SNTI $8.14M	–	–	–	–
124	SQZ 124 DELISTED SQZ Biotechnologies Company SQZ	–	–	–	–
125	TCBP 125 DELISTED TC BioPharm (Holdings) plc American Depositary Shares TCBP	–	–	–	–